Drreddys Laboratories | RDY - Loan Capital


Drreddys Laboratories reported INR129.19M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
ANI Pharmaceuticals USD 297.68M 310.67M Sep/2025
Aurora Cannabis CAD 34.99M 1.31M Sep/2025
Bayer EUR 32.71B 1B Sep/2025
Canopy Growth CAD 226.33M 62.67M Sep/2025
Cipla INR 2.98B 454.6M Sep/2025
Drreddys Laboratories INR 129.19M 1.84M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Hikma Pharmaceutical USD 798M 191M Jun/2025
Lonza CHF 4.24B 602M Dec/2024
Novartis USD 24.24B 174M Sep/2025
Pacira USD 376.72M 1.37M Sep/2025
Prestige Brands USD 1.05B 39.73M Dec/2025
Richter Gedeon HUF 15.68B 100M Sep/2025
Sun Pharmaceuticals INR 3.62B 36.4M Sep/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025